Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional Study.
Martorell-Calatayud A, Santos-Alarcón S, Sahuquillo-Torralba A, Rivera-Díaz R, Belinchón-Romero I, Ruiz-Genao D, Romero-Maté A, Ruiz-Villaverde R, Ferran-Farrés M, Gallardo-Hernández F, Almenara-Blasco M, Suarez-Perez JA, González-Cantero Á, Martínez-Lorenzo E, Fernández-Armenteros JM, Del Alcázar-Viladomiu E, García-Latasa J, Rocamora-Durant V, Ara-Martín M, Mateu-Puchades A, Llamas-Velasco M, Vilarrasa E, Velasco-Pastor M, De la Cueva P, Carrascosa JM, Magdaleno-Tapial J. Martorell-Calatayud A, et al. Among authors: carrascosa jm. Actas Dermosifiliogr. 2024 Oct 23:S0001-7310(24)00854-8. doi: 10.1016/j.ad.2024.10.042. Online ahead of print. Actas Dermosifiliogr. 2024. PMID: 39454868 English, Spanish.
Treatment of atopic dermatitis with abrocitinib in real practice in Spain: efficacy and safety results from a 24-week multicenter study.
Armario-Hita JC, Pereyra-Rodriguez JJ, González-Quesada A, Herranz P, Suarez R, Galan-Gutiérrez M, Rodríguez-Serna M, Ortiz de Frutos J, Carrascosa JM, Serra-Baldrich E, Ara-Martin M, Figueras-Nart I, Silvestre JF, Zaragoza-Ninet V, Ruiz-Villaverde R. Armario-Hita JC, et al. Among authors: carrascosa jm. Int J Dermatol. 2024 Nov;63(11):e289-e295. doi: 10.1111/ijd.17344. Epub 2024 Jun 21. Int J Dermatol. 2024. PMID: 39425593
Publisher Correction: Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment.
Silverberg JI, Wollenberg A, Stein Gold L, Del Rosso J, Yosipovitch G, Lio P, Carrascosa JM, Gallo G, Ding Y, Xu Z, Casillas M, Pierce E, Agell H, Ständer S. Silverberg JI, et al. Among authors: carrascosa jm. Dermatol Ther (Heidelb). 2024 Nov;14(11):3195-3196. doi: 10.1007/s13555-024-01269-y. Dermatol Ther (Heidelb). 2024. PMID: 39424713 Free PMC article. No abstract available.
Allergic contact dermatitis in adults with and without atopic dermatitis: Evaluation of the Spanish Contact Dermatitis Registry (REIDAC).
Chicharro P, Munera-Campos M, Zaragoza-Ninet V, Giménez-Arnau A, González-Pérez R, Miquel-Miquel FJ, Córdoba-Guijarro S, Sanz-Sánchez T, Ruiz-González I, Silvestre-Salvador JF, Serra-Baldrich E, Borrego L, Pastor-Nieto MA, Ortiz de Frutos FJ, Mercader-García P, Heras-Mendaza F, Fernández-Redondo V, Rodríguez-Serna M, Hervella-García M, Carrascosa JM, Gallego-Descalzo MA, García-Doval I, Sánchez-Pérez J. Chicharro P, et al. Among authors: carrascosa jm. Contact Dermatitis. 2024 Nov;91(5):404-411. doi: 10.1111/cod.14672. Epub 2024 Aug 13. Contact Dermatitis. 2024. PMID: 39138883
Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment.
Silverberg JI, Wollenberg A, Stein Gold L, Del Rosso J, Yosipovitch G, Lio P, Carrascosa JM, Gallo G, Ding Y, Xu Z, Casillas M, Pierce E, Agell H, Ständer S. Silverberg JI, et al. Among authors: carrascosa jm. Dermatol Ther (Heidelb). 2024 Aug;14(8):2249-2260. doi: 10.1007/s13555-024-01226-9. Epub 2024 Aug 10. Dermatol Ther (Heidelb). 2024. PMID: 39123054 Free PMC article.
Cutaneous Pseudolymphoma after COVID-19 Vaccine Injection.
Verdaguer-Faja J, Valdivieso L, Fabregat-Pratdepadua M, Melendo GT, Quer A, Carrascosa JM, Boada A. Verdaguer-Faja J, et al. Among authors: carrascosa jm. Indian J Dermatol. 2024 May-Jun;69(3):269-272. doi: 10.4103/ijd.ijd_420_22. Epub 2024 Jun 26. Indian J Dermatol. 2024. PMID: 39119314 Free PMC article. No abstract available.
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials.
Silverberg JI, Wollenberg A, Reich A, Thaçi D, Legat FJ, Papp KA, Stein Gold L, Bouaziz JD, Pink AE, Carrascosa JM, Rewerska B, Szepietowski JC, Krasowska D, Havlíčková B, Kalowska M, Magnolo N, Pauser S, Nami N, Sauder MB, Jain V, Padlewska K, Cheong SY, Fleuranceau Morel P, Ulianov L, Piketty C; ARCADIA 1 and ARCADIA 2 Study Investigators. Silverberg JI, et al. Among authors: carrascosa jm. Lancet. 2024 Aug 3;404(10451):445-460. doi: 10.1016/S0140-6736(24)01203-0. Epub 2024 Jul 24. Lancet. 2024. PMID: 39067461 Clinical Trial.
Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials.
Bissonnette R, Warren RB, Pinter A, Agner T, Gooderham M, Schuttelaar MLA, Crépy MN, Stingeni L, Serra-Baldrich E, Baranowski K, Korn S, Kurvits M, Plohberger U, Strange Vest N, Schliemann S; trial investigators. Bissonnette R, et al. Lancet. 2024 Aug 3;404(10451):461-473. doi: 10.1016/S0140-6736(24)01027-4. Epub 2024 Jul 18. Lancet. 2024. PMID: 39033766 Clinical Trial.
Consensus Statement from the Spanish Academy of Dermatology and Venereology (AEDV) Psoriasis Working Group (SWG) and Pediatric Working Group (PWG) on the Management of Pediatric Psoriasis.
Vicente A, Pérez-Ferriols A, Batalla A, García-Fernandez L, Pérez B, Eiris N, de Lucas R, De La Cueva P, Carrascosa JM. Vicente A, et al. Among authors: carrascosa jm. Actas Dermosifiliogr. 2024 Jul 18:S0001-7310(24)00597-0. doi: 10.1016/j.ad.2024.06.007. Online ahead of print. Actas Dermosifiliogr. 2024. PMID: 39032783 English, Spanish.
338 results